361 related articles for article (PubMed ID: 24867961)
1. Intravenous Vitamin C and Cancer: A Systematic Review.
Fritz H; Flower G; Weeks L; Cooley K; Callachan M; McGowan J; Skidmore B; Kirchner L; Seely D
Integr Cancer Ther; 2014 Jul; 13(4):280-300. PubMed ID: 24867961
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.
Hoffer LJ; Robitaille L; Zakarian R; Melnychuk D; Kavan P; Agulnik J; Cohen V; Small D; Miller WH
PLoS One; 2015; 10(4):e0120228. PubMed ID: 25848948
[TBL] [Abstract][Full Text] [Related]
3. Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review.
Jacobs C; Hutton B; Ng T; Shorr R; Clemons M
Oncologist; 2015 Feb; 20(2):210-23. PubMed ID: 25601965
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.
Bazzan AJ; Zabrecky G; Wintering N; Newberg AB; Monti DA
Integr Cancer Ther; 2018 Sep; 17(3):912-920. PubMed ID: 29771164
[TBL] [Abstract][Full Text] [Related]
5. High-Dose Vitamin C in Advanced-Stage Cancer Patients.
Zasowska-Nowak A; Nowak PJ; Ciałkowska-Rysz A
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652579
[TBL] [Abstract][Full Text] [Related]
6. Effects of High Doses of Vitamin C on Cancer Patients in Singapore: Nine Cases.
Raymond YC; Glenda CS; Meng LK
Integr Cancer Ther; 2016 Jun; 15(2):197-204. PubMed ID: 26679971
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.
Mikirova N; Casciari J; Riordan N; Hunninghake R
J Transl Med; 2013 Aug; 11():191. PubMed ID: 23947403
[TBL] [Abstract][Full Text] [Related]
8. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].
Xu SN; Chen JP; Liu JP; Xia Y
Zhong Xi Yi Jie He Xue Bao; 2009 Nov; 7(11):1024-34. PubMed ID: 19912733
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Vitamin C for Cancer Therapy - Identifying the Current Gaps in Our Knowledge.
Carr AC; Cook J
Front Physiol; 2018; 9():1182. PubMed ID: 30190680
[TBL] [Abstract][Full Text] [Related]
10. Vitamin C and Cancer: The Role of Vitamin C in Disease Progression and Quality of Life in Cancer Patients.
Abiri B; Vafa M
Nutr Cancer; 2021; 73(8):1282-1292. PubMed ID: 32691657
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study.
Chen P; Reed G; Jiang J; Wang Y; Sunega J; Dong R; Ma Y; Esparham A; Ferrell R; Levine M; Drisko J; Chen Q
Clin Pharmacokinet; 2022 Sep; 61(9):1237-1249. PubMed ID: 35750958
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review.
van Gorkom GNY; Lookermans EL; Van Elssen CHMJ; Bos GMJ
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31035414
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma lucidum (Reishi mushroom) for cancer treatment.
Jin X; Ruiz Beguerie J; Sze DM; Chan GC
Cochrane Database Syst Rev; 2012 Jun; (6):CD007731. PubMed ID: 22696372
[TBL] [Abstract][Full Text] [Related]
14. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials.
Block KI; Koch AC; Mead MN; Tothy PK; Newman RA; Gyllenhaal C
Cancer Treat Rev; 2007 Aug; 33(5):407-18. PubMed ID: 17367938
[TBL] [Abstract][Full Text] [Related]
15. High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy.
Ma Y; Chapman J; Levine M; Polireddy K; Drisko J; Chen Q
Sci Transl Med; 2014 Feb; 6(222):222ra18. PubMed ID: 24500406
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of oral and intravenous vitamin C use in patients with malignant diseases.
Hoppe C; Freuding M; Büntzel J; Münstedt K; Hübner J
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3025-3042. PubMed ID: 34402972
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
[TBL] [Abstract][Full Text] [Related]
18. The acute effect of high-dose intravenous vitamin C and other nutrients on blood pressure: a cohort study.
Ried K; Travica N; Sali A
Blood Press Monit; 2016 Jun; 21(3):160-7. PubMed ID: 26910646
[TBL] [Abstract][Full Text] [Related]
19. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.
Amarasena IU; Walters JA; Wood-Baker R; Fong K
Cochrane Database Syst Rev; 2008 Oct; (4):CD006849. PubMed ID: 18843733
[TBL] [Abstract][Full Text] [Related]
20. Sequential versus concurrent paclitaxel and carboplatin for the treatment of advanced non-small cell lung cancer in elderly patients and patients with poor performance status: results of two Phase II, multicenter trials.
Marsland TA; Garfield DH; Khan MM; Look RM; Boehm KA; Asmar L
Lung Cancer; 2005 Jan; 47(1):111-20. PubMed ID: 15603861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
